Navigating Pharmacovigilance: Comprehensive Signal, Risk Management & Aggregate Report Solutions
Aggregate Universe: PSUR, PBRER, PADER, ASR, ACO, BRER, J-PSUR
Team Expertise: NCEs, Biologics, Combination Product, Generics
By leveraging advanced technologies and robust methodologies, we detect, prioritize, and evaluate safety signals, ensuring timely interventions and optimal patient outcomes.
Team works with SAS enabaled Quantitative analysis & Physician Grey matter enabaled Qualitative analysis. We are equipped with team of MDs & Scientists to drive your signal at the compliant place.
We have a concept called Signal Detection Algorithm (SDA). Based on product, volume, Region & likelyhood of signals, our experts derive algorithim and creates curated methodology. Such efforts have also been apllauded in recent inspection.
Team Expertise: NCEs, Biologics, Combination Product, Vaccines, Generics
Our experience in the development of risk management systems is very pragmatic for pharmaceuticals, biosimilars, combination products, vaccines and biologics; this differentiates us from other CROs. Our agile process and experience of working with different size of companies put us as frontrunners when it comes to integration with sponsor’s safety CMO groups in arriving at comprehensive material ready RMPs for submission to the regulatory agency.
COD has team members who worked as expert in managing single shared REMS programs mandated by the FDA. We do provide experts assistance to our manufacturers through REMS development process.
Automating aRMM tracking enhances process efficiency and accuracy, offering streamlined audit trails, automatic report generation, and robust data integrity. This ensures compliance, real-time monitoring, informed decision-making, and scalable growth.
At COD, our hands-on industry experts have developed with our software development partner through advanced automation technology.
By leveraging advanced analytics and regulatory expertise, we empower organizations to proactively manage risks, ensuring compliance and enhancing patient safety throughout the product lifecycle. We invite proposals that align with our commitment to excellence in pharmacovigilance practices